atacand
Treatment for Cluster Headache
Atacand (candesartan), an angiotensin II receptor blocker (ARB), has been found to potentially reduce the frequency and severity of cluster headaches by modulating vascular tone and neurogenic inflammation through antagonism of AT1 receptors. Its mechanism involves blocking angiotensin II's vasoconstrictive effects, which may help regulate cerebral blood flow and reduce the trigeminovascular system's inflammatory response associated with cluster headache pathogenesis.